Androgen receptor inhibitor–induced “BRCAness” and PARP inhibition are synthetically lethal for castration-resistant prostate cancerLikun Li, Timothy C. Thompson, Styliani Karanika et al.|Science Signaling|2017Cited by 307
Targeting the MYCN–PARP–DNA Damage Response Pathway in Neuroendocrine Prostate CancerYaoguang Zhang, Timothy C. Thompson, Dimitrios Korentzelos et al.|Clinical Cancer Research|2017Cited by 108
Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 SignalingStyliani Karanika, Timothy C. Thompson, Theodoros Karantanos et al.|Cell Reports|2017Cited by 107
Targeting Poly(ADP-Ribose) Polymerase and the c-Myb–Regulated DNA Damage Response Pathway in Castration-Resistant Prostate CancerLikun Li, Timothy C. Thompson, Wenjun Chang et al.|Science Signaling|2014Cited by 87
PARP Inhibition Suppresses GR–MYCN–CDK5–RB1–E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate CancerBo Liu, Timothy C. Thompson, Likun Li et al.|Clinical Cancer Research|2019Cited by 78